Product
PG-102(MG12)
1 clinical trial
2 indications
Indication
HealthyIndication
ObesityClinical trial
A Double-blind, Randomized, Placebo Controlled, Combined Single and Multiple Ascending Dose, Phase 1 Study to Investigate the Safety, Tolerability and Pharmacokinetic and Pharmacodynamics of PG-102(MG12) in Healthy VolunteersStatus: Recruiting, Estimated PCD: 2024-06-26